Xenon Pharmaceuticals (XENE) Quick Ratio: History & Chart

Xenon Pharmaceuticals Inc.(XENE)

Biotechnology · Burnaby, BC

$36.39-1.18 (-3.14%)

Delayed quote: Oct 6, 2026, 3:50 PM EDT

About Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company dedicated to discovering and advancing innovative treatments for individuals living with neurological disorders. The company operates primarily from its headquarters in Burnaby, Canada. Its robust clinical pipeline showcases several promising candidates: XEN496, an activator of Kv7 potassium channels, is currently in Phase III clinical trials for KCNQ2 developmental and epileptic encephalopathy. Another Kv7 potassium channel activator, XEN1101, is progressing through Phase II trials, targeting epilepsy and a range of other neurological conditions. The portfolio also includes NBI-921352, a selective inhibitor of the Nav1.6 sodium channel, which is undergoing Phase II clinical evaluation for SCN8A developmental and epileptic encephalopathy, alongside investigations for adult focal epilepsy and other potential indications. Furthermore, XEN007, a central nervous system-acting calcium channel modulator, is also in Phase II development. Beyond its internal development, Xenon Pharmaceuticals has established strategic collaborations. This includes a licensing and development agreement with Neurocrine Biosciences, Inc. focused on epilepsy treatments, and a partnership with Flexion Therapeutics, Inc. to advance PCRX301 (also known as XEN402), a Nav1.7 inhibitor, for post-operative pain management. Established in 1996, the company continues its mission to address significant unmet medical needs in neurology.

Burnaby, BC

364 employees

www.xenon-pharma.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Ian C. Mortimer

View full financials

XENE Quick Ratio (Acid-Test) Metrics

QUICK RATIO (ACID-TEST)

21.02

QUICK RATIO (ACID-TEST) AVG TTM

17.98

QUICK RATIO (ACID-TEST) AVG 3Y

19.61

QUICK RATIO (ACID-TEST) AVG 5Y

22.94

QUICK RATIO (ACID-TEST) AVG 10Y

18.36

QUICK RATIO (ACID-TEST) AVG 15Y

15.45

QUICK RATIO (ACID-TEST) AVG 20Y

N/A

CURRENT VS TTM AVG

+16.90%

CURRENT VS 3Y AVG

+7.16%

CURRENT VS 5Y AVG

-8.39%

CURRENT VS 10Y AVG

+14.46%

CURRENT VS 15Y AVG

+36.06%

CURRENT VS 20Y AVG

N/A

SECTOR MEDIAN · HEALTHCARE

3.35

median of 871 covered companies

CURRENT VS SECTOR MEDIAN

+527.32%

vs the sector median at left

NAME	MARKET CAP	QUICK RATIO (ACID-TEST)	TTM	3Y	5Y
Xenon Pharmaceuticals Inc. (XENE)	$3.52B	21.02	17.98	19.61	22.94
iRhythm Technologies, Inc. (IRTC)vs ›	$3.53B	3.75	5.09	3.82	4.05
Veracyte, Inc. (VCYT)vs ›	$3.55B	8.80	6.13	5.10	7.69
Celcuity Inc. (CELC)vs ›	$3.47B	8.93	9.13	14.29	16.91
IDEAYA Biosciences, Inc. (IDYA)vs ›	$3.48B	10.45	13.16	14.41	11.78
Tango Therapeutics, Inc. (TNGX)vs ›	$3.57B	50.82	11.65	9.40	9.07
Pulse Biosciences, Inc. (PLSE)vs ›	$3.43B	9.61	11.20	9.88	7.68
Regencell Bioscience Holdings Limited (RGC)vs ›	$3.65B	1.42	24.66	24.27	16.20
Acadia Pharmaceuticals Inc. (ACAD)vs ›	$3.38B	3.30	3.01	3.08	4.22
Parabilis Medicines, Inc. (PBLS)vs ›	$3.37B	17.91	1.68	1.68	1.68

NAME

MARKET CAP

QUICK RATIO (ACID-TEST)

TTM

Xenon Pharmaceuticals Inc. (XENE)

$3.52B

21.02

17.98

19.61

22.94

iRhythm Technologies, Inc. (IRTC)vs ›

$3.53B

3.75

5.09

3.82

4.05

Veracyte, Inc. (VCYT)vs ›

$3.55B

8.80

6.13

5.10

7.69

Celcuity Inc. (CELC)vs ›

$3.47B

8.93

9.13

14.29

16.91

IDEAYA Biosciences, Inc. (IDYA)vs ›

$3.48B

10.45

13.16

14.41

11.78

Tango Therapeutics, Inc. (TNGX)vs ›

$3.57B

50.82

11.65

9.40

9.07

Pulse Biosciences, Inc. (PLSE)vs ›

$3.43B

9.61

11.20

9.88

7.68

Regencell Bioscience Holdings Limited (RGC)vs ›

$3.65B

1.42

24.66

24.27

16.20

Acadia Pharmaceuticals Inc. (ACAD)vs ›

$3.38B

3.30

3.01

3.08

4.22

Parabilis Medicines, Inc. (PBLS)vs ›

$3.37B

17.91

1.68

Quick Ratio (Acid-Test) FAQ

What is the quick ratio (acid-test) for Xenon Pharmaceuticals Inc. (XENE)?

The quick ratio (acid-test) for XENE stock is 21.02.

Is Xenon Pharmaceuticals Inc.'s quick ratio (acid-test) high or low?

The quick ratio (acid-test) of 21.02 is in line with its 5-year average of 22.94, near the low end of its 5-year range (12.52–68.36).

What is the TTM average quick ratio (acid-test) for Xenon Pharmaceuticals Inc. (XENE)?

The TTM average quick ratio (acid-test) for XENE stock is 17.98.

What is the 3Y average quick ratio (acid-test) for Xenon Pharmaceuticals Inc. (XENE)?

The 3Y average quick ratio (acid-test) for XENE stock is 19.61.

What is the 5Y average quick ratio (acid-test) for Xenon Pharmaceuticals Inc. (XENE)?

The 5Y average quick ratio (acid-test) for XENE stock is 22.94.

What is the 10Y average quick ratio (acid-test) for Xenon Pharmaceuticals Inc. (XENE)?

The 10Y average quick ratio (acid-test) for XENE stock is 18.36.

What is the 15Y average quick ratio (acid-test) for Xenon Pharmaceuticals Inc. (XENE)?

The 15Y average quick ratio (acid-test) for XENE stock is 15.45.

DATE	QUICK RATIO (ACID-TEST)
2026-06-30	21.02
2026-03-31	27.79
2025-12-31	13.42
2025-09-30	12.52
2025-06-30	15.14
2025-03-31	17.66
2024-12-31	17.85
2024-09-30	22.21
2024-06-30	23.27
2024-03-31	31.82
2023-12-31	23.65
2023-09-30	21.46
2023-06-30	19.34
2023-03-31	23.71
2022-12-31	26.44
2022-09-30	41.78
2022-06-30	57.86
2022-03-31	68.36
2021-12-31	39.03
2021-09-30	19.94
2021-06-30	17.81
2021-03-31	24.65
2020-12-31	12.30
2020-09-30	11.52
2020-06-30	9.83
2020-03-31	4.82
2019-12-31	3.34
2019-09-30	8.25
2019-06-30	11.07
2019-03-31	17.57
2018-12-31	29.48
2018-09-30	29.34
2018-06-30	20.80
2018-03-31	9.68
2017-12-31	10.98
2017-09-30	14.71
2017-06-30	13.95
2017-03-31	16.47
2016-12-31	18.68
2016-09-30	17.95
2016-06-30	18.23
2016-03-31	20.29
2015-12-31	21.88
2015-09-30	12.39
2015-06-30	6.20
2015-03-31	7.51
2014-12-31	5.95
2014-09-30	2.95
2014-06-30	2.62
2014-03-31	0.00
2013-12-31	2.74
2013-09-30	0.00
2013-06-30	2.86
2013-03-31	2.86
2012-12-31	3.16
2012-09-30	3.16

DATE

QUICK RATIO (ACID-TEST)

2026-06-30

21.02

2026-03-31

27.79

2025-12-31

13.42

2025-09-30

12.52

2025-06-30

15.14

2025-03-31

17.66

2024-12-31

17.85

2024-09-30

22.21

2024-06-30

23.27

2024-03-31

31.82

2023-12-31

23.65

2023-09-30

21.46

2023-06-30

19.34

2023-03-31

23.71

2022-12-31

26.44

2022-09-30

41.78

2022-06-30

57.86

2022-03-31

68.36

2021-12-31

39.03

2021-09-30

19.94

2021-06-30

17.81

2021-03-31

24.65

2020-12-31

12.30

2020-09-30

11.52

2020-06-30

9.83

2020-03-31

4.82

2019-12-31

3.34

2019-09-30

8.25

2019-06-30

11.07

2019-03-31

17.57

2018-12-31

29.48

2018-09-30

29.34

2018-06-30

20.80

2018-03-31

9.68

2017-12-31

10.98

2017-09-30

14.71

2017-06-30

13.95

2017-03-31

16.47

2016-12-31

18.68

2016-09-30

17.95

2016-06-30

18.23

2016-03-31

20.29

2015-12-31

21.88

2015-09-30

12.39

2015-06-30

6.20

2015-03-31

7.51

2014-12-31

5.95

2014-09-30

2.95

2014-06-30

2.62

2014-03-31

0.00

2013-12-31

2.74

2013-09-30

0.00

2013-06-30

2.86

2013-03-31

2.86

2012-12-31

3.16

2012-09-30

3.16

Quick Ratio (Acid-Test): 21.02

XENE Quick Ratio

XENE Average Quick Ratio (Acid-Test) Chart

XENE Current vs Average Quick Ratio (Acid-Test) Chart

XENE Quick Ratio (Acid-Test) Metrics

XENE Competitors' Quick Ratio (Acid-Test)

Liquidity Comparison

Quick Ratio (Acid-Test) Formula & Definition

Quick Ratio (Acid-Test) FAQ

XENE Quick Ratio (Acid-Test) History

Related Metrics